BioLife Solutions, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
BioLife Solutions, Inc. (BLFS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$156.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2022-05-10
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-03-31 was -$156.00K.
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-12-31 was -$119.00K.
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-09-30 was -$166.00K.
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-06-30 was $3.00K.
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$282.00K.
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was $0.00.
- BioLife Solutions, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was $0.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$156.00K 10-Q · filed 2022-05-10 | -$275.00K derived: sum of 2 quarters · filed 2022-05-10 | -$441.00K derived: sum of 3 quarters · filed 2022-05-10 | -$438.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$285.00K derived: sum of 2 quarters · filed 2022-03-31 | -$282.00K derived: sum of 3 quarters · filed 2022-03-31 | -$282.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | -$166.00K 10-Q · filed 2021-11-15 | -$163.00K derived: sum of 2 quarters · filed 2021-11-15 | -$163.00K 10-Q · filed 2021-11-15 | -$163.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-06-30 | $3.00K 10-Q · filed 2021-08-16 | $3.00K 10-Q · filed 2021-08-16 | $3.00K derived: sum of 3 quarters · filed 2022-05-10 | $3.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-05-10 | $0.00 derived: sum of 3 quarters · filed 2022-05-10 | $0.00 derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |